Literature DB >> 24842112

Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL).

Merete Haedersdal1, Fernanda H Sakamoto, William A Farinelli, Apostolos G Doukas, Joshua Tam, R Rox Anderson.   

Abstract

BACKGROUND AND OBJECTIVES: 5-Aminolevulinic acid (ALA) and methyl aminolevulinate (MAL) are porphyrin precursors used topically for photodynamic therapy (PDT). Previous studies have established that ablative fractional laser (AFXL) increases topical drug uptake. We evaluated kinetics and biodistribution of ALA- and MAL-induced porphyrins on intact and disrupted skin due to AFXL.
MATERIALS AND METHODS: Two Yorkshire swine were exposed to CO2 AFXL (10.6 µm, 1,850 µm ablation depth) and subsequent topical application of ALA and MAL cream formulations (20%, weight/weight). Porphyrin fluorescence was quantified by digital fluorescence photography (30, 90, and 180 minutes) and fluorescence microscopy at specific skin depths (180 minutes).
RESULTS: Porphyrins gradually formed over time, differently on intact and AFXL-disrupted skin. On intact skin (no AFXL), fluorescence photography showed that MAL initially induced higher fluorescence than ALA (t = 30 minutes MAL 21.1 vs. ALA 7.7 au, t = 90 minutes MAL 39.0 vs. ALA 26.6 (P < 0.009)) but reached similar intensities for long-term applications (t = 180 minutes MAL 56.6 vs. ALA 52 au, P = ns). AFXL considerably enhanced porphyrin fluorescence from both photosensitizers (P < 0.05). On AFXL-exposed skin, MAL expressed higher fluorescence than ALA for short-term application (t = 30 minutes, AFXL-MAL 26.4 vs. AFXL-ALA 14.1 au, P < 0.001), whereas ALA over time overcame MAL and induced the highest fluorescence intensities obtained (t = 180 minutes, AFXL-MAL 98.6 vs. AFXL-ALA 112.0 au, P < 0.001). In deep skin layers, fluorescence microscopy showed higher fluorescence in hair follicle epithelium for ALA than MAL (t = 180 minutes, 1.8 mm, AFXL-MAL 35.3 vs. AFXL-ALA 46.7 au, P < 0.05).
CONCLUSIONS: AFXL changes kinetics and biodistribution of ALA and MAL. It appears that AFXL-ALA favors targeting deep structures.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablative fractional laser; drug delivery; fluorescence microscopy; fluorescence photography; protoporphyrin IX

Mesh:

Substances:

Year:  2014        PMID: 24842112     DOI: 10.1002/lsm.22259

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  8 in total

Review 1.  Laser-assisted drug delivery in dermatology: from animal models to clinical practice.

Authors:  Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

2.  Utilizing non-ablative fractional photothermolysis prior to ALA-photodynamic therapy in the treatment of acne vulgaris: a case series.

Authors:  Sarah Qureshi; Jennifer Y Lin
Journal:  Lasers Med Sci       Date:  2016-10-14       Impact factor: 3.161

3.  Laser facilitates week-long sustained transdermal drug delivery at high doses.

Authors:  Prateek Kakar; Zhuofan Li; Yibo Li; Yan Cao; Xinyuan Chen
Journal:  J Control Release       Date:  2020-01-07       Impact factor: 9.776

4.  Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy.

Authors:  Connor Thunshelle; Rui Yin; Qiquan Chen; Michael R Hamblin
Journal:  Curr Dermatol Rep       Date:  2016-07-13

5.  Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.

Authors:  Masayoshi Kawakubo; Shadmehr Demehri; Dieter Manstein
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

Review 6.  Update of Ablative Fractionated Lasers to Enhance Cutaneous Topical Drug Delivery.

Authors:  Jill S Waibel; Ashley Rudnick; Deborah R Shagalov; Danielle M Nicolazzo
Journal:  Adv Ther       Date:  2017-07-07       Impact factor: 3.845

Review 7.  The Potential of CRISPR-Guided Therapies in the Dermatology Clinic.

Authors:  Prashant Bhat; Lilit Garibyan
Journal:  JID Innov       Date:  2022-01-25

8.  The Efficacy and Safety of Fractional CO₂ Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study.

Authors:  Jie Zhu; Xi Ji; Min Li; Xiao-e Chen; Juan Liu; Jia-an Zhang; Dan Luo; Bing-rong Zhou
Journal:  Biomed Res Int       Date:  2016-02-22       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.